News | January 12, 2009

Cardima to Exhibit, Host Symposium at 45th Annual STS Meeting

January 13, 2009 - Cardima Inc. plans to showcase its atrial fibrillation treatment products and technologies at the 45th Annual Meeting of the Society of Thoracic Surgeons (STS) conference Jan. 26-28, 2009 in San Francisco.

Cardima will also sponsor a breakfast symposium at the STS conference entitled, "Surgical Ablation - Keys to Success." The symposium will highlight Cardima's Surgical Ablation System and feature prominent speakers including:

- Li Poa, M.D., FACS, chief of Cardiothoracic Surgery and Cardiac Surgery Program Director at Stamford Hospital and faculty member of Columbia University. Dr. Poa is among the world's leading authorities on surgical ablation for the treatment of atrial fibrillation (AF) and is head of the Cardima Center of Excellence and Training Program at Stamford Hospital. He has conducted extensive work perfecting thoracoscopic surgical techniques, and will train cardiothoracic surgeons in the use of the Cardima Surgical Ablation System.

- Sanjeev Saksena, M.D., FHRS, FACC, FESC FAHA, clinical professor of Medicine, Robert Wood Johnson School of Medicine and medical director of the Electrophysiology Research Foundation. Dr. Saksena was the director of the Cardiovascular Institute, Atlantic Health System (Eastern Campus) from 1999-2004 and is a past president of the North American Society of Pacing and Electrophysiology (NASPE). He is the founding editor and current editor-in-chief of the Journal of Interventional Cardiac Electrophysiology. Dr. Saksena is also a Planning/Steering Committee member of the National Institute of Health AFFIRM & TOPCAT trials that have focused on atrial fibrillation.

The Surgical Ablation System uses Cardima's patented technology for the ablation of cardiac tissue. The system incorporates a microcatheter-based surgical probe coupled with Cardima's INTELLITEMP, a radiofrequency energy management device. The probe incorporates irrigation, suction and illumination, which aid in placement and lesion depth. The Cardima Surgical Ablation System is reportedly able to create deep, long, linear and transmural cardiac lesions without gaps, and the small, flexible design offers sole port-hole access, potentially decreasing procedure time, patient hospital stay and discomfort.

The breakfast symposium will be held at the San Francisco Marriott on Jan. 27 at 6:00 a.m. For additional details, please contact Dilyana Hadjeva at [email protected] About Cardima Surgical Ablation System

For more information:

Related Content

CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018
Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first...
FDA Approves Biosense Webster's Tag-Index Guided Ablation Software
Technology | Ablation Systems | October 09, 2018
Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for its Visitag...
Medtronic Cryoballoon Improves Quality of Life, Reduces Systems of Persistent Atrial Fibrillation
News | Ablation Systems | August 28, 2018
Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life...
Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter
News | Ablation Systems | August 02, 2018
Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device...
Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
Overlay Init